2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation

Journal of the Formosan Medical Association

Tsu-Juey Wu¹  Jyh-Hong Chen²  Li-Jen Lin²  Kwo-Chang Ueng³  Chun-Chieh Wang⁴  Ming-Shien Wen⁴  San-Jou Yeh⁴  Chen-Chuan Cheng⁵  Mien-Cheng Chen⁶  Kun-Tai Lee⁷  Wen-Ter Lai⁷  Jen-Yuan Kuo⁸  Lian-Yu Lin⁹  Chia-Ti Tsai⁹  Yen-Bin Liu⁹  Jiunn-Lee Lin⁹  Wen-Jone Chen⁹  Kuan-Cheng Chang^1,10  Tze-Fan Chao^1,11  Chuen-Wang Chiou^1,11  Shih-Ann Chen^1,11  Yenn-Jiang Lin^1,11  Wei-Shiang Lin^1,12  Kang-Ling Wang^1,13  Chern-En Chiang^1,13  Yi-Jen Chen^1,14  Wei-Hsian Yin^1,15 

[1] Cardiovascular Center, Department of Internal Medicine, Taichung Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan;Department of Internal Medicine, National Cheng Kung University College of Medicine and Hospital, Tainan, Taiwan;Department of Internal Medicine, School of Medicine, Chung-Shan Medical University (Hospital), Taichung, Taiwan;Department of Internal Medicine, Section of Cardiology, Chang Gung University College of Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan;Division of Cardiology, Chi Mei Medical Center, Tainan, Taiwan;Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan;Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;Division of Cardiology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan;Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan;Division of Cardiology, Department of Medicine, China Medical University Hospital, Taichung, Taiwan;Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;Division of Cardiology, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan;General Clinical Research Center, Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan;Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan;Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan;

关键词: ablation;    antiarrhythmic agents;    anticoagulation;    atrial fibrillation;    non-vitamin K antagonist oral anticoagulant;    vitamin K antagonist;   

DOI  :  10.1016/j.jfma.2016.10.005

来源: DOAJ

【 摘 要 】

Atrial fibrillation (AF) is the most common sustained arrhythmia. Both the incidence and prevalence of AF are increasing, and the burden of AF is becoming huge. Many innovative advances have emerged in the past decade for the diagnosis and management of AF, including a new scoring system for the prediction of stroke and bleeding events, the introduction of non-vitamin K antagonist oral anticoagulants and their special benefits in Asians, new rhythm- and rate-control concepts, optimal endpoints of rate control, upstream therapy, life-style modification to prevent AF recurrence, and new ablation techniques. The Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology aimed to update the information and have appointed a jointed writing committee for new AF guidelines. The writing committee members comprehensively reviewed and summarized the literature, and completed the 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the Management of Atrial Fibrillation. This guideline presents the details of the updated recommendations, along with their background and rationale, focusing on data unique for Asians. The guidelines are not mandatory, and members of the writing committee fully realize that treatment of AF should be individualized. The physician's decision remains most important in AF management.

【 授权许可】

Unknown